Aberdeen Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $145M | Buy |
|
|||||
|
2025
Q2 | $128M | Buy |
|
|||||
|
2025
Q1 | $123M | Buy |
|
|||||
|
2024
Q4 | $98.8M | Sell |
|
|||||
|
2024
Q3 | $130M | Buy |
|
|||||
|
2024
Q2 | $118M | Sell |
|
|||||
|
2024
Q1 | $123M | Sell |
|
|||||
|
2023
Q4 | $129M | Buy |
|
|||||
|
2023
Q3 | $71.2M | Sell |
|
|||||
|
2023
Q2 | $79.4M | Buy |
|
|||||
|
2023
Q1 | $87.9M | Buy |
|
|||||
|
2022
Q4 | $102M | Buy |
|
|||||
|
2022
Q3 | $81.7M | Buy |
|
|||||
|
2022
Q2 | $85.5M | Sell |
|
|||||
|
2022
Q1 | $89.2M | Sell |
|
|||||
|
2021
Q4 | $166M | Sell |
|
|||||
|
2021
Q3 | $123M | Sell |
|
|||||
|
2021
Q2 | $114M | Sell |
|
|||||
|
2021
Q1 | $113M | Buy |
|
|||||
|
2020
Q4 | $96.5M | Sell |
|
|||||
|
2020
Q3 | $98.4M | Sell |
|
|||||
|
2020
Q2 | $97.9M | Buy |
|
|||||
|
2020
Q1 | $94.7M | Sell |
|
|||||
|
2019
Q4 | $140M | Sell |
|
|||||
|
2019
Q3 | $143M | Sell |
|
|||||
|
2019
Q2 | $210M | Sell |
|
|||||
|
2019
Q1 | $243M | Sell |
|
|||||
|
2018
Q4 | $479M | Sell |
|
|||||
|
2018
Q3 | $508M | Sell |
|
|||||
|
2018
Q2 | $440M | Buy |
|
|||||
|
2018
Q1 | $410M | Sell |
|
|||||
|
2017
Q4 | $439M | Sell |
|
|||||
|
2017
Q3 | $450M | Buy |
|